Associations between Eating Behaviours and Psychological Characteristics with Body Mass Index Change and Appetite-Related Changes during Incretin-Based Therapy
Authors:
- Ali KapanAli Kapan
- Sandra HaiderSHSandra Haider
- Othmar MoserOMOthmar Moser
- Thomas WaldhoerThomas Waldhoer
- Richard FelsingerRFRichard Felsinger
Open Access
- 11 December 2025
- journal article
- Published by S. Karger AG in Obesity Facts
- Vol. 19 (4) , 1
Abstract
Introduction: The aim of this study was to examine associations between psychological and behavioural factors and body weight, appetite, satiety, and food cravings in individuals with obesity receiving incretin therapy. Methods: Between January and February 2025, 411 adults completed an online survey. They provided data using the Weight Efficacy Lifestyle Questionnaire – Short Form, the Three-Factor Eating Questionnaire, and the Salzburg Emotional Eating Scale, and rated their perceptions of satiety, appetite, and food cravings. Multivariable linear and logistic regression analyses were used to assess associations between psychological factors and these outcomes, adjusting for relevant confounders. Results: The sample was mainly female (71.8%), with a median age of 40 years (Q1–Q3: 33–47). Participants had a median treatment duration of 43 weeks (Q1–Q3: 30–58) and a median body mass index (BMI) difference of 5.9 kg/m2 (Q1–Q3: 4.0–7.4). In fully adjusted models, higher self-efficacy was associated with lower BMI values (β = −0.22; p < 0.001) and greater satiety (adjusted odds ratio [AOR] = 1.46; p < 0.001). Emotional eating in response to happiness was related to higher BMI (β = 0.46; p < 0.001) but also to higher satiety and lower cravings (AOR = 1.31–1.41; p < 0.05). Conclusion: Eating self-efficacy and emotion-related eating patterns were linked to body weight, appetite, satiety, and cravings. Considering these psychological profiles may help tailor behavioural support, improve adherence, and enhance the effectiveness of incretin-based therapy.Keywords
This publication has 26 references indexed in Scilit:
- Incretin‐based therapies for the management of cardiometabolic disease in the clinic: Past, present, and futureMedicinal Research Reviews, 2024
- GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)? A systematic reviewJournal of Clinical & Translational Endocrinology, 2024
- Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesityPhysiology & Behavior, 2022
- Análogos de GLP1 en los pacientes con sobrepeso u obesidad durante el confinamientoMedicina Clinica, 2022
- Eating behavior modulates the sensitivity to the central effects of GLP-1 receptor agonist treatment: a secondary analysis of a randomized trialPsychoneuroendocrinology, 2022
- Emotional eating across different eating disorders and the role of body mass, restriction, and binge eatingInternational Journal of Eating Disorders, 2021
- The effects of GLP-1 analogues in obese, insulin-using type 2 diabetes in relation to eating behaviourInternational Journal of Clinical Pharmacy, 2015
- Emotional eating is associated with increased brain responses to food‐cues and reduced sensitivity to GLP‐1 receptor activationObesity, 2015
- Eating self-efficacy: Development of a short-form WELEating Behaviors, 2012
- Using self-efficacy to predict weight loss among young adultsJournal of the American Dietetic Association, 2003